chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes just above my collar bone on each side.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medication included estradiol-noreth (MANUFACTURER UNKNOWN) since an unknown date for an unknown indication. The patient had no past drug therapy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021 at 09:00, the patient experienced swollen lymph nodes just above her collar bone on each side. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event swollen lymph nodes just above her collar bone on each side was not resolved at the time of the report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GR8737) via an unspecified route of administration in the left arm on 20Apr2021 at 11:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Daily bloody noses; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the arm left on 21Apr2021 at 13:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 the patient experienced daily bloody noses. The clinical outcome of the event daily bloody noses was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Facial pain, Headache, Neck pain
Clinical narrative: During dose 2, injection made into acromioclavicular rather than deltoid muscle; Persistent pain; Back pain; Neck pain; Face pain; Shoulder pain; Head pain only on side of injection (left); This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 29Apr2021 at 10:00 (at the age of 23-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 23-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 10:00, the patient experienced persistent pain which resulted in shoulder pain, back pain, neck pain, face pain and head pain only on side of injection (left). The patient reported, during dose 2, injection made into acromioclavicular rather than deltoid muscle as directed. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events persistent pain, back pain, neck pain, face pain, shoulder pain and head pain only on side of injection (left) was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Product administered at inappropriate site
Clinical narrative: During dose 2, injection made into acromioclavicular rather than deltoid muscle; Persistent pain; Back pain; Neck pain; Face pain; Shoulder pain; Head pain only on side of injection (left); This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 29Apr2021 at 10:00 (at the age of 23-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 23-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 10:00, the patient experienced persistent pain which resulted in shoulder pain, back pain, neck pain, face pain and head pain only on side of injection (left). The patient reported, during dose 2, injection made into acromioclavicular rather than deltoid muscle as directed. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events persistent pain, back pain, neck pain, face pain, shoulder pain and head pain only on side of injection (left) was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal dreams, Agitation, Anxiety
Clinical narrative: Extreme Agitation; Anxiety; Extreme Agitation and Anxiety but most disturbing are the vivid dreams; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP6955) via an unspecified route of administration in the left arm on 18Mar2021 at 16:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0150) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Medical history of the patient included none. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 00:00 the patient experienced extreme agitation and anxiety but most disturbing were the vivid dreams. The clinical outcome of the events extreme agitation, anxiety and vivid dreams were not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Intense Nose Bleed; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Apr2021 at 13:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), turmeric pills (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN) all started on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 12:15, the patient experienced intense nose bleed. The clinical outcome of the event intense nose bleed was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: Right eyebrow twitch, twitch in bridge of my nose, brow and right ear.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 03Apr2021(at the age of 52-year-old) as a single dose for COVID-19 immunization. Medical history included psoriasis and high cholesterol. Concomitant medications included adalimumab (HUMIRA) for unknown indication from an unknown date. The patient's past drug history was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 04Apr2021, the patient experienced right eyebrow twitch since the day after receiving vaccine. The patient sometimes felt the twitching in the bridge of the nose, brow and right ear. Twitching lasts just for few seconds and sometimes every five minutes or longer in between, but throughout the day for over 4 weeks. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event facial twitching was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Face became numb; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 17Apr2021 at 14:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8734) via an unspecified route of administration in the left arm on 27Mar2021 at 14:00 (at the age of vaccination 40-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 00:00 after two weeks of vaccination, the patient experienced face became numb. The clinical outcome of the event face numbness was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleeds every 4-6 hours; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the arm right on 28Apr2021 at 14:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm right on 07Apr2021 at 14:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01May2021 at 13:00, the patient experienced nose bleeds every 4-6 hours since Saturday from the same nostril. The patient had no nose bleeds in years. The clinical outcome of nose bleeds every 4-6 hours was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Chills; Tiredness; Headache; Muscle pain; Fever; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received an unknown dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0172) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown date. Concomitant medications included salbutamol (ALBUTEROL) and fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), both for unknown indications from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.  On 12Apr2021, the patient underwent nasal swab test  and the result was negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 15:45, the patient experienced chills, tiredness, headache, fever and muscle pain. The clinical outcome of the events of  chills, tiredness, headache, fever and muscle pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Chills; Tiredness; Headache; Muscle pain; Fever; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received an unknown dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0172) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown date. Concomitant medications included salbutamol (ALBUTEROL) and fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), both for unknown indications from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.  On 12Apr2021, the patient underwent nasal swab test  and the result was negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 15:45, the patient experienced chills, tiredness, headache, fever and muscle pain. The clinical outcome of the events of  chills, tiredness, headache, fever and muscle pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Cyanopsia
Clinical narrative: Outside after dark, the grass under and near the street lamp appeared to be blue/cyan in color. The patient did not notice again until the next day at work when the normally light grey work screen appeared blue/cyan momentarily.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 29Apr2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and reported no allergies but reacted to antibiotics in the fluoroquinolone group. The patient had received medication (unspecified) within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E0153) via an unspecified route of administration in the left arm on 08Apr2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 22:30, the patient experienced while outside after dark, grass under and near the street lamp appeared to be blue/cyan in color. This lasted as long as the patient was outside for about 15 minutes. The patient did not notice again until the next day at work when normally light grey work screen appeared blue/cyan momentarily. It came and went within a few seconds. The clinical outcome of the event grass under and near the street lamp appeared to be blue/cyan in color and screen appeared blue/cyan was unknown at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash macular, Rash papular, Rash pruritic
Clinical narrative: Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; raised rash; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 16:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, allergy to sulpha based drugs, IVP dye, some shellfish. Concomitant medications included levothyroxine sodium (SYNTHROID), azelastine hydrochloride (ASTELIN), lorazepam (MANUFACTURER UNKNOWN), multivitamin (MANAFACTURER UNKNOWN), calci (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Mar2021 at 16:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 10:00 the patient experienced red, raised, hot, painful, itchy blotches of rash throughout torso front and back, thighs, neck and lower left arm. The clinical outcome of events red rash, raised rash, skin warm, painful rash, itchy rash, blotchy rash was recovered on an unspecified date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; raised rash; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 16:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, allergy to sulpha based drugs, IVP dye, some shellfish. Concomitant medications included levothyroxine sodium (SYNTHROID), azelastine hydrochloride (ASTELIN), lorazepam (MANUFACTURER UNKNOWN), multivitamin (MANAFACTURER UNKNOWN), calci (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Mar2021 at 16:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 10:00 the patient experienced red, raised, hot, painful, itchy blotches of rash throughout torso front and back, thighs, neck and lower left arm. The clinical outcome of events red rash, raised rash, skin warm, painful rash, itchy rash, blotchy rash was recovered on an unspecified date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue, Lymphadenitis, Pyrexia
Clinical narrative: mild fever, chills, fatigue, moderate lower back muscle pain for up to 3 days, inflammed lymph nodes in both armpits.; mild fever, chills, fatigue, moderate lower back muscle pain for up to 3 days, inflammed lymph nodes in both armpits.; mild fever, chills, fatigue, moderate lower back muscle pain for up to 3 days, inflammed lymph nodes in both armpits.; mild fever, chills, fatigue, moderate lower back muscle pain for up to 3 days, inflammed lymph nodes in both armpits.; mild fever, chills, fatigue, moderate lower back muscle pain for up to 3 days, inflammed lymph nodes in both armpits.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0172) via an unspecified route of administration in the left arm on 30Apr2021 at 16:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient medical history and past drug history was reported as no. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the left arm on 09Apr2021 at 10:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 18:00, the patient experienced mild fever, chills, fatigue, moderate lower back muscle pain for up to three days and inflammed lymph nodes in both armpits. The clinical outcome of the events mild fever, chills, fatigue, moderate lower back muscle pain for up to three days was resolved on 03May2021 and of inflammed lymph nodes was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chills, Lymphadenopathy, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: had a sore throat; chills; had a swollen lymph node on neck; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on an unknown date (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and past drug therapy. The patient did not take any medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 22Apr2021, the patient experienced sore throat and chills for a few hours and swollen lymph node on the neck. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included blood test on an unknown date and was waiting on results and COVID-19 test on an unknown date and the results were unknown. The clinical outcome of the events sore throat and chills was recovered on an unknown date in Apr2021 and the outcome of the event swollen lymph node on the neck was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, SARS-CoV-2 test
Clinical narrative: Left Eye is still twitching on the bottom lens Constantly  all day and night long.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) in the left arm on 09Apr2021 at 11:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) in the right arm on 03May2021 at 10:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any medication within two weeks of vaccination. No past drug therapy was provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 10Apr2021 at 16:00 the patient experienced left eye is still twitching on the bottom lens constantly  all day and night long. On 12Apr2021, the patient underwent  Rapid Antigen test and the result was negative. The clinical outcome of the event eyelid twitching was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash macular, Urticaria
Clinical narrative: itchy red spots anywhere across the body at one or two places at a time; itchy red spots anywhere across the body at one or two places at a time; sometimes accompanied with hives like spots.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 09:45 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included benidipine hydrochloride (BENITOWA) for hypertension from unknown date. The past drug name was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 07:00, the patient experienced itchy red spots anywhere across the body at one or two places at a time sometimes accompanied with hives like spots. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of itchy red spots anywhere across the body at one or two places at a time sometimes accompanied with hives like spots and included treatment with benadryl (antihistamine). The clinical outcome of the event itchy, itchy red spots and hives like spots was recovering at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: Hard knot the size of an egg in the armpit in the injected arm.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 13:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included levonorgestrel (MIRANA) Intrauterine Device (IUD) used 7 years for birth control. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 14:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 27Apr2021 at 13:30, the patient experienced hard knot the size of an egg in the armpit in the injected arm. The clinical outcome of the event hard knot the size of an egg in the armpit in the injected arm was not resolved.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Urticaria, nonpruritic, without any systemic complaints otherwise; This is a spontaneous report from a non-contactable nurse. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications were not reported. The patient previously did not receive any medications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, 2 days after the COVID shot, the patient experienced urticaria, nonpruritic, without any systemic complaints otherwise. The patient had COVID 3 months ago and towards the end developed similar presentation of urticaria. These 2 events were the only time he had ever had urticarial lesions in his life. The event resulted in emergency room/department visit or urgent care. Therapeutic measures were taken as a result of urticaria, nonpruritic, without any systemic complaints otherwise which included treatment with antihistamines. The clinical outcome of the event urticaria, nonpruritic, without any systemic complaints otherwise was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Hyperhidrosis, Joint stiffness
Clinical narrative: Dizziness; Sweating; joint stiffness; fatigue; Severe Headache; Nausea; severe pain at vaccination sight; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), in the right arm on 11Apr2021 at 12:30(at the age of 54-year-old), as a dose for COVID-19 immunisation followed by second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) in the left arm on 01May2021 at 12:30 (at the age of 54-year-old), as a dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced dizziness, sweating, joint stiffness, fatigue, severe headache, nausea and severe pain at vaccination site. The clinical outcome of the events dizziness, sweating, joint stiffness, fatigue, severe headache, nausea and severe pain at vaccination sight was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain
Clinical narrative: Dizziness; Sweating; joint stiffness; fatigue; Severe Headache; Nausea; severe pain at vaccination sight; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), in the right arm on 11Apr2021 at 12:30(at the age of 54-year-old), as a dose for COVID-19 immunisation followed by second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) in the left arm on 01May2021 at 12:30 (at the age of 54-year-old), as a dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced dizziness, sweating, joint stiffness, fatigue, severe headache, nausea and severe pain at vaccination site. The clinical outcome of the events dizziness, sweating, joint stiffness, fatigue, severe headache, nausea and severe pain at vaccination sight was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Petechiae
Clinical narrative: Petechiae all over face, neck, chest; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01May2021 at 13:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02May2021 at 13:00, the patient experienced petechiae all over her face, neck and chest. The clinical outcome of the event petechiae all over the face, neck, chest was not resolved at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Oropharyngeal pain
Clinical narrative: sore throat; Tiredness; headache; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167), via an unspecified route of administration in the left arm on 03May2021 at 13:00 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162), via an unspecified route of administration in the left arm on 26Apr2021 at 10:00 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 17:00, the patient experienced tiredness, sore throat and headache. The clinical outcome of the events tiredness, sore throat and headache was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain around vaccination site; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8734) via an unspecified route of administration in the left arm on 08Apr2021 at 15:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included iron (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN) and clarithromycin (CLARITIN) all started on an unknown date for an unknown indication. The patient had no past drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 19:00, the patient experienced pain around vaccination site. The clinical outcome of the event pain around the vaccination site was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain
Clinical narrative: Pain in left armpit; swelling on left armpit; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8735) via an unspecified route of administration in the left arm on 01May2021 at 16:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient not had any past medication history. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8734) via an unspecified route of administration in the left arm on 08April2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 20:00, the patient experienced pain in left armpit and swelling in left armpit (axillary mass).  The clinical outcome of the event pain in left armpit and swelling in left armpit( axillary mass) was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes on right side in neck, near collarbone, and armpit.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the arm right on 30Apr2021 at 12:00(at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included episcleritis, granuloma annulare, acid reflux, and latex allergy (slight skin irritation from latex product). Concomitant medications esomeprazole (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), vitamin d nos (VIT D) and prednisolone (MANUFACTURER UNKNOWN); all from unknown date for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021, the patient experienced swollen lymph nodes on right side in neck, near collarbone, and armpit. The clinical outcome of the event swollen lymph nodes on right side in neck, near collarbone, and armpit. was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Fatigue; Headache; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 03May2021 at 16:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. Patient did not receive any medications in the past. Patient did not receive any medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04May2021, the patient experienced fatigue, headache, fever and chills. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, headache, fever and chills were unknown at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: Skin rash; swelling of lymph nodes in left armpit (same arm where the injection was received); This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 01May2021 at 16:30(at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not received any concomitant medication. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10Apr2021 at 12:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021, the patient experienced skin rash and swelling of lymph nodes in left armpit (same arm where the injection was received by patient). The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events skin rash and swelling of lymph nodes in left armpit was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Diarrhoea, Fatigue, Headache
Clinical narrative: Fever (102); Nausea; Vomiting; Diarrhea; Fatigue; Loss of appetite; Headache; Localized pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 21Apr2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, COVID-19 and known allergy to cephalosporins. Concomitant medications included paracetamol (TYLENOL), ibuprofen (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and etodolac (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 21:00, the patient experienced fever (102), localized pain at injection site, nausea, vomiting, diarrhea, fatigue, loss of appetite and headache. On 21Apr2021, the body temperature was reported as 102 (unit unspecified). The clinical outcome of the events fever (102), localized pain at injection site, nausea, vomiting, diarrhea, fatigue, loss of appetite and headache was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: Fever (102); Nausea; Vomiting; Diarrhea; Fatigue; Loss of appetite; Headache; Localized pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 21Apr2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, COVID-19 and known allergy to cephalosporins. Concomitant medications included paracetamol (TYLENOL), ibuprofen (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and etodolac (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 21:00, the patient experienced fever (102), localized pain at injection site, nausea, vomiting, diarrhea, fatigue, loss of appetite and headache. On 21Apr2021, the body temperature was reported as 102 (unit unspecified). The clinical outcome of the events fever (102), localized pain at injection site, nausea, vomiting, diarrhea, fatigue, loss of appetite and headache was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.